Gender-Responsive Drug Use Treatment for Juvenile Justice Girls

Completed · Not applicable

Conditions studied: Drug Use

In brief

Girls in the juvenile justice system have unique developmental pathways to drug use and co-occurring risk (e.g., HIV/STI) behaviors that have typically not been considered or tested in order to identify evidence-based gender-specific substance use treatment approaches for this population. This study will advance scientific knowledge and clinical practice in the drug treatment and public health fields by testing the efficacy of a pre-existing, widely disseminated gender-responsive substance use treatment (VOICES) on drug use and HIV/STI risk behavior outcomes for a broad range of substance using girls and young women (ages 12-24) who are at-risk for or already involved with the justice system.

Key facts

Study ID

NCT02293057

Run by

University of California, San Francisco

People needed

132

Starts

2014-09-01

Expected to finish

2020-09-01

Last updated by the study team

2020-12-23

Who can join

Age: 12 and older, up to 24. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 130 court-involved, non-incarcerated (CINI) female juvenile offenders or those at-risk for court-involvement, ages 12-24, who report any alcohol, marijuana or other drug use in the past 90 days will be eligible for enrollment with the following criteria:
• Determined to be in need of substance use treatment by the court intake worker, probation officer, presiding judge or magistrate, and/or school counselor; 2) Legal guardian available to consent for child's participation, if the child is under the age of 18, and 3) Child is English speaking.

You may not qualify if…

• meet DSM-V criteria for substance use disorder with current severity rating of severe (6 or more symptoms) (as determined through referral partner);
• already in substance use treatment (residential or outpatient) and wish to remain with outside provider (as determined through referral partner);
• observable cognitive or developmental delays or active psychosis that would interfere with completing consent, assessment or intervention.

Where it is running

• UCSF Zuckerberg San Francisco General Hospital — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.